Dr. Amaiak Chilingaryan, MD

Dr. Chilingaryan practices at Central Surgery Center of Glendale in Glendale, California.

Dr. Chilingaryan's NPI, 1134433568, was assigned on July 27, 2010. Dr. Chilingaryan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009. Dr. Chilingaryan holds California license A113714.

Dr. Chilingaryan's primary practice is Central Surgery Center of Glendale, at 800 S Central Ave, Glendale, CA 91204 in Los Angeles County. The practice phone is (626) 484-0606.

Dr. Chilingaryan's primary practice is Central Surgery Center of Glendale in Glendale, California. Dr. Chilingaryan is also affiliated with Adventist Health Glendale. The medical group on file is Axon Neurology. Dmand AI also links Dr. Chilingaryan to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chilingaryan practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chilingaryan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chilingaryan is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Chilingaryan is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Chilingaryan treats.

CMS data shows 7,761 Medicare services from Dr. Chilingaryan across 24 procedure codes in 2024, for 941 Medicare patients. Medicare paid $667,584 for them.

CMS counts 941 Medicare patients who saw Dr. Chilingaryan in 2024. The largest group is 65 to 74, with 460 patients. 75% of them have arthritis, and 75% have high blood pressure. 94% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chilingaryan's median patient age at 61, with 62% women.

In 2024, Dr. Chilingaryan wrote 8,488 Medicare Part D claims for 673 patients. 79% of them were for generic drugs. CMS names the drug for 8,231 of them, across 85 drugs with 11 or more claims each, at $3,026,230 in total drug cost. In 2023, CMS named 8,840 claims across 86 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chilingaryan for performance year 2024, reported individually. Dr. Chilingaryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chilingaryan as offering telehealth.

Dmand AI links 4 papers to Dr. Chilingaryan, published from 2006 to 2015. The most frequent topics are Calcium-Transporting ATPases and Staining and Labeling. Dr. Chilingaryan's most frequent co-authors are Said R. Beydoun, MD and Richard Alan Rison, MD.

CMS Open Payments shows 1,337 general payments to Dr. Chilingaryan from 79 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. UCB, Inc. paid the most, $3,082.

Dr. Chilingaryan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009.

Dr. Chilingaryan is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.